Emergent BioSolutions (NYSE:EBS) is 17.5% lower postmarket after the disclosure of a pair of insiders selling stock.

Director Sue Bailey disclosed selling 5,322 shares on Wednesday, at an average price of $87.503, for proceeds of about $465,691. That move leaves her with direct beneficial ownership of 37,260 shares.

Director Ronald Richard sold shares the same day: 6,572 shares at an average price of $87.514, for proceeds of about $575,142. That leaves him with 4,269 shares.

READ FULL ARTICLE HERE